ストックスクリーナーアプリを入手
325.03
0.36%
1.18
Insulet Corporation (PODD) 最新ニュース
Goldman Sachs Initiates Coverage of Insulet (PODD) with Buy Rating - MSN
Goldman Sachs Initiates Coverage of Insulet (BIT:1PODD) with Buy Recommendation - Nasdaq
Insulet (NASDAQ:PODD) Now Covered by The Goldman Sachs Group - Defense World
Goldman Sachs Initiates Coverage of Insulet (PODD) with Buy Recommendation - Nasdaq
Goldman Sachs Initiates Coverage on Insulet (PODD) with Buy Rati - GuruFocus
Goldman Sachs Initiates Coverage on Insulet (PODD) with a Buy Ra - GuruFocus
Goldman Sachs initiates coverage of medtech stocks Insulet and Dexcom at Buy - Investing.com
Goldman Sachs Initiates Insulet at Buy With $380 Price Target - marketscreener.com
Goldman Sachs starts Insulet stock with buy, $380 target By Investing.com - Investing.com South Africa
Goldman Sachs starts Insulet stock with buy, $380 target - Investing.com
Goldman Sachs Starts Insulet Corporation (PODD) at Buy - StreetInsider
Insulet (NASDAQ:PODD) Upgraded by Wall Street Zen to “Buy” Rating - Defense World
Goldman Sachs Initiates Coverage on Insulet (PODD) with Positive Outlook | PODD Stock News - GuruFocus
Insulet initiated with a Buy at Goldman Sachs - TipRanks
Questions About High-Flying Insulet Corp. - Law Street Media
Insulet Corporation (PODD) Announces Approval of 2025 Stock Opti - GuruFocus
Insulet Corporation: Shares Remain Astronomically Expensive (NASDAQ:PODD) - Seeking Alpha
Insulet Corporation Holds 2025 Annual Stockholders Meeting - TipRanks
Is Insulet Corporation (NASDAQ:PODD) A High Quality Stock To Own? - Yahoo Finance
What Is Insulet Corporation's (NASDAQ:PODD) Share Price Doing? - simplywall.st
Here's How Much $100 Invested In Insulet 15 Years Ago Would Be Worth Today - Benzinga
Raymond James Increases Price Target for Insulet (PODD) to $360 - GuruFocus
Insulet (NASDAQ:PODD) Price Target Raised to $360.00 at Raymond James - Defense World
Insulet Gains 78.5% in a Year: What's Driving the Stock? - MSN
Insulet (PODD) Target Price Raised by Raymond James | PODD Stock News - GuruFocus
Raymond James Increases Price Target for Insulet (PODD) to $360 | PODD Stock News - GuruFocus
Raymond James Adjusts Price Target on Insulet to $360 From $328, Maintains Outperform Rating - marketscreener.com
Insulet stock target lifted to $360 by Raymond James - Investing.com India
Insulet Corporation (PODD) PT Raised to $360 at Raymond James - StreetInsider
Cetera Investment Advisers Has $631,000 Position in Insulet Co. (NASDAQ:PODD) - Defense World
(PODD) Technical Data - news.stocktradersdaily.com
Insulet Foe Rips $30M Atty Fee Ask As 'Over-Lawyered' - Law360
Insulet to Present at the Goldman Sachs 46th Annual Global Healt - GuruFocus
Do Wall Street Analysts Like Insulet Stock? - MSN
Insulet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 - Eagle-Tribune
Analysts Turn Bullish on Insulet Stock (PODD) after Strong Q1 Earnings - MSN
5 Analysts Assess Insulet: What You Need To KnowInsulet (NASDAQ:PODD) - Benzinga
Insulet (PODD) Price Target Raised by Citigroup to $380 | PODD Stock News - GuruFocus
Zacks Industry Outlook Highlights Insulet, MacroGenics, Cellectar Biosciences and Allurion Technologies - Yahoo Finance
Citigroup Adjusts Price Target on Insulet to $380 From $320, Maintains Buy Rating - marketscreener.com
Citi adds Edwards Lifesciences stock as Top Pick, drops Insulet - Investing.com
Global Insulin Pumps Market Report 2021-2030: Insulet, - openPR.com
Insulet stock soars to 52-week high, reaches $326.53 By Investing.com - Investing.com South Africa
Insulet stock soars to 52-week high, reaches $326.53 - Investing.com
Captrust Financial Advisors Raises Stake in Insulet Co. (NASDAQ:PODD) - Defense World
Here's What to Expect From Insulet's Next Earnings Report - MSN
Insulet Adds Stryker Executive to Board - Medical Product Outsourcing
Insulet Creates Medical Director Position - Medical Product Outsourcing
Insulet stock price target raised to $375 by Bernstein - Investing.com Australia
'Insulet Corporation (PODD) is Our Top Pick in Diabetes'; PT Raised to $375 at Bernstein - StreetInsider
Here's Why Insulet (PODD) is a Strong Momentum Stock - Yahoo Finance
Bernstein Boosts Insulet (PODD) Price Target Amid Strong Market Position | PODD Stock News - GuruFocus
Insulet’s SVP Cashes In: A Multi-Million Dollar Stock Sale! - TipRanks
Insulet (PODD) – Investment Analysts’ Weekly Ratings Changes - Defense World
Insulet Names New CEO, Expects to Top Revenue Projections - MSN
Insulet Surges on Q1 Beat, Emerges as a Top S&P 500 Performer - MSN
Why Insulet (PODD) is a Top Growth Stock for the Long-Term - Yahoo Finance
Bernstein Adjusts Insulet Price Target to $375 From $355 - marketscreener.com
0.09%
1.38%
大文字化:
|
ボリューム (24 時間):